2,829
Views
5
CrossRef citations to date
0
Altmetric
Original Research

A Comparative Efficacy Evaluation of Recombinant Topical Thrombin (RECOTHROM®) With A Gelatin Sponge Carrier Versus Topical Oxidized Regenerated Cellulose (TABOTAMP®/SURGICEL®) In A Porcine Liver Bleeding Model

, , , , &

References

  • Ghadimi K, Levy JH, Welsby IJ. Perioperative management of the bleeding patient. Br J Anaesth. 2016;117(suppl 3):iii18–iii30. doi:10.1093/bja/aew358.
  • Tackett SM, Sugarman R, Kreuwel HT, et al. Hospital economic impact from hemostatic matrix usage in cardiac surgery. J Med Econ. 2014;17(9):670–676. doi:10.3111/13696998.2014.928638.
  • Carson JL, Stanworth SJ, Roubinian N, et al. Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion. Cochrane Database Syst Rev. 2016;10:CD002042. doi:10.1002/14651858.CD002042.pub4.
  • Ramirez Manuel G, Castillo George F, Ramirez Manuel A. The economic burden of bleeds and transfusions in selected surgeries: A retrospective multi center analysis from the US perspective. Am J Biomed Sci Res. 2019;2(5):211–216. doi:10.34297/AJBSR.2019.02.000610.
  • Pedziwiatr M, Malczak P, Pisarska M, et al. Minimally invasive versus open pancreatoduodenectomy-systematic review and meta-analysis. Langenbecks Arch Surg. 2017;402(5):841–851. doi:10.1007/s00423-017-1583-8.
  • Hughes MJ, Ventham NT, Harrison EM, et al. Central venous pressure and liver resection: a systematic review and meta-analysis. HPB (Oxford). 2015;17(10):863–871. doi:10.1111/hpb.12462.
  • Staerkle RF, Hoffmann H, Kockerling F, et al. Does coagulopathy, anticoagulant or antithrombotic therapy matter in incisional hernia repair? Data from the Herniamed Registry. Surg Endosc. 2018;32(9):3881–3889. doi:10.1007/s00464-018-6127-y.
  • Grottke O, Fries D, Nascimento B. Perioperatively acquired disorders of coagulation. Curr Opin Anaesthesiol. 2015;28(2):113–122. doi:10.1097/ACO.0000000000000176.
  • Bennett KM, Kent KC, Schumacher J, et al. Targeting the most important complications in vascular surgery. J Vasc Surg. 2017;65(3):793–803. doi:10.1016/j.jvs.2016.08.107.
  • Vyas KS, Saha SP. Comparison of hemostatic agents used in vascular surgery. Expert Opin Biol Ther. 2013;13(12):1663–1672. doi:10.1517/14712598.2013.848193.
  • Lewis KM, Spazierer D, Urban MD, et al. Comparison of regenerated and non-regenerated oxidized cellulose hemostatic agents. Eur Surg. 2013;45(4):213–220. doi:10.1007/s10353-013-0222-z.
  • Chiara O, Cimbanassi S, Bellanova G, et al. A systematic review on the use of topical hemostats in trauma and emergency surgery. BMC Surg. 2018;18(1):68. doi:10.1186/s12893-018-0398-z.
  • Samudrala S. Topical hemostatic agents in surgery: a surgeon's perspective. AORN J. 2008;88(3):S2–S11. doi:10.1016/S0001-2092(08)00586-3.
  • Price JS, Tackett S, Patel V. Observational evaluation of outcomes and resource utilization from hemostatic matrices in spine surgery. J Med Econ. 2015;18(10):777–786. doi:10.3111/13696998.2015.1046879.
  • Bracey A, Shander A, Aronson S, et al. The use of topical hemostatic agents in cardiothoracic surgery. Ann Thorac Surg. 2017;104(1):353–360. doi:10.1016/j.athoracsur.2017.01.096.
  • Moss R. Management of surgical hemostasis: an independent study guide. 2013. https://www.aorn.org/-/media/aorn/guidelines/tool-kits/medication-safety/management-of-surgical-hemostasis-independent-study-guide.pdf?la=en&hash=9FED3DF8BFDEF8B1C8D1899F8FC7BE79. Accessed July 2019.
  • Lewis KM, Li Q, Jones DS, et al. Development and validation of an intraoperative bleeding severity scale for use in clinical studies of hemostatic agents. Surgery. 2017;161(3):771–781. doi:10.1016/j.surg.2016.09.022.
  • Lewis KM, Atlee HD, Mannone AJ, et al. Comparison of two gelatin and thrombin combination hemostats in a porcine liver abrasion model. J Invest Surg. 2013;26(3):141–148. doi:10.3109/08941939.2012.724519.
  • MacDonald MH, Wang AY, Clymer JW, et al. An in vivo comparison of the efficacy of hemostatic powders, using two porcine bleeding models. Med Devices (Auckl). 2017;10:273–279. doi:10.2147/MDER.S140663.
  • Committee for the Update of the Guide for the Care and Use of Laboratory Animals. Guide for the Care and Use of Laboratory Animals. https://grantsnihgov/grants/olaw/guide-for-the-care-and-use-of-laboratory-animalspdf. 2011. Accessed July 2019.
  • Slezak P, Keibl C, Redl H, et al. An efficacy comparison of two hemostatic agents in a porcine liver bleeding model: Gelatin/thrombin flowable matrix versus collagen/thrombin powder. J Invest Surg. 2019. [Epub ahead of print]. doi:10.1080/08941939.2019.1571130.
  • Baxter Healthcare Corporation. RECOTHROM Thrombin topical (Recombinant) Prescribing Information. https://advancedsurgery.baxter.com/sites/g/files/ebysai1521/files/2019-02/Recothrom%20PI_Oct%202018.pdf. Published 2018. Accessed September 2019.
  • Ethicon SARL. SURGICEL® Original Absorbable Hemostat Instructions for Use. https://hostedvl106.quosavl.com/qb/doc/7tet975fdm64l9f9qdpo6470us. Published 2016. Accessed July 2019.
  • Ethicon Inc. SPONGOSTAN™ Absorbable Hemostatic Gelatin Sponge Instructions for Use. https://webroot146.s3.amazonaws.com/img/catalogues/ethicon-spongostan-sponge-IFU.pdf. Published 2010. Accessed September 2019.
  • Vitello DJ, Ripper RM, Fettiplace MR, et al. Blood density is nearly equal to water density: A validation study of the gravimetric method of measuring intraoperative blood loss. J Vet Med. 2015;2015:1–4. doi:10.1155/2015/152730.
  • Chapman WC, Lockstadt H, Singla N, et al. Phase 2, randomized, double-blind, placebo-controlled, multicenter clinical evaluation of recombinant human thrombin in multiple surgical indications. J Thromb Haemost. 2006;4(9):2083–2085. doi:10.1111/j.1538-7836.2006.02067.x.
  • Hughes SD, Bishop PD, Garcia R, et al. Topical recombinant thrombin at a concentration of 1000 IU/mL reliably shortens in vivo TTH and delivers durable hemostasis in the presence of heparin anticoagulation and clopidogrel platelet inhibition in a rabbit model of vascular bleeding. Ann Surg Innov Res. 2009;3(1):14. doi:10.1186/1750-1164-3-14.
  • Testini M, Marzaioli R, Lissidini G, et al. The effectiveness of FloSeal matrix hemostatic agent in thyroid surgery: a prospective, randomized, control study. Langenbecks Arch Surg. 2009;394(5):837–842. doi:10.1007/s00423-009-0497-5.
  • Kakaei F, Seyyed Sadeghi MS, Sanei B, et al. A randomized clinical trial comparing the effect of different haemostatic agents for haemostasis of the liver after hepatic resection. HPB Surg. 2013;2013:1–5. doi:10.1155/2013/587608.
  • Badenes D, Pijuan L, Curull V, et al. A foreign body reaction to Surgicel((R)) in a lymph node diagnosed by endobronchial ultrasound-guided transbronchial needle aspiration. Ann Thorac Med. 2017;12(1):55–56. doi:10.4103/1817-1737.197780.
  • Gao HW, Lin CK, Yu CP, et al. Oxidized cellulose (Surgicel) granuloma mimicking a primary ovarian tumor. Int J Gynecol Pathol. 2002;21(4):422–423. doi:10.1097/00004347-200210000-00015.
  • Sandhu GS, Elexpuru-Camiruaga JA, Buckley S. Oxidized cellulose (Surgicel) granulomata mimicking tumour recurrence. Br J Neurosurg. 1996;10(6):617–619. doi:10.1080/02688699646989.
  • Wang H, Chen P. Surgicel((R)) (oxidized regenerated cellulose) granuloma mimicking local recurrent gastrointestinal stromal tumor: A case report. Oncol Lett. 2013;5(5):1497–1500. doi:10.3892/ol.2013.1218.
  • Arora ND, Varghese R, Pavithran S, et al. The pressures of surgicel((R)) in cardiac surgery. Ann Pediatr Card. 2015;8(2):167–169. doi:10.4103/0974-2069.157040.
  • Banerjee T, Goldschmidt K. Surgiceloma' manifested as cauda equina syndrome. South Med J. 1998;91(5):481–483. doi:10.1097/00007611-199805000-00016.
  • Rustagi T, Patel K, Kadrekar S, et al. Oxidized cellulose (surgicel) causing Postoperative Cauda Equine Syndrome. Cureus. 2017;9(7):e1500. doi:10.7759/cureus.1500.
  • Knowlson GT. Gel-foam granuloma in the brain. J Neurol Neurosurg Psychiatry. 1974;37(8):971–973. doi:10.1136/jnnp.37.8.971.
  • Epstein NE, Silvergleid RS, Hollingsworth R. Increased postoperative cervical myelopathy and cord compression resulting from the use of Gelfoam. Spine J. 2009;9(2):e19–21. doi:10.1016/j.spinee.2008.03.009.
  • Herndon JH, Grillo HC, Riseborough EJ, et al. Compression of the brain and spinal cord following use of gelfoam. Arch Surg. 1972;104(1):107. doi:10.1001/archsurg.1972.04180010101027.
  • Gazzeri R, Galarza M, Neroni M, et al. Hemostatic matrix sealant in neurosurgery: a clinical and imaging study. Acta Neurochir. 2011;153(1):148–155. discussion 155. doi:10.1007/s00701-010-0762-y.
  • Gazzeri R, De Bonis C, Galarza M. Use of a thrombin-gelatin hemostatic matrix (Surgiflo) in spinal surgery. Surg Technol Int. 2014;25:280–285.